Telomir Pharmaceuticals, Inc. (TELO): Shares Outstanding
34.38M
As of 2025-12-31
68.77M
As of 2026-06-30
+8.6%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 34.38M | +15.5% | 2026-03-17, Balance as of period end |
| 2024-12-31 | 29.76M | +4.0% | 2026-03-17, Balance as of period end |
| 2023-12-31 | 28.61M | +6.6% | 2025-02-04, Balance as of period end |
| 2022-12-31 | 26.83M | n/a | 2024-03-29, Balance as of period end |